WallStSmart
GLTO

Galecto Inc

NASDAQ: GLTO · HEALTHCARE · BIOTECHNOLOGY

$24.16
-7.65% today

Updated 2026-06-02

Market cap
$43.73M
P/E ratio
P/S ratio
EPS (TTM)
$-12.11
Dividend yield
52W range
$2 – $38
Volume
0.3M

Galecto Inc (GLTO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2018201920202021202220232024
Operating cash flow$-13.69M$-19.33M$-38.20M$-52.31M$-42.93M$-36.91M$-18.62M
Capital expenditures$223000.00$223000.00$223000.00$223000.00$196000.00$83000.00$0.00
Depreciation
Stock-based comp$81000.00$374000.00$982000.00$4.48M$5.57M$5.43M$3.24M
Free cash flow$-13.91M$-19.55M$-38.43M$-52.53M$-43.13M$-36.99M$-18.62M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash$-30.04M

Frequently asked questions

How much free cash flow does GLTO generate?

GLTO produced $-18.62M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.